Skip Nav Destination
Issues
15 October 2015
-
Cover Image
Cover Image
A stable, fluorescently labeled zebrafish melanoma cell line derived from transgenic mitfa-BRAFV600E;p53−/−;mitfa-GFP fish was transplanted into casper, a transparent adult zebrafish. Green fluorescent melanoma cells metastasize to various regions of the transparent host fish over time. Shown here are sequential images of a tumor transplant that enable the quantitative assessment of metastatic spread in vivo. For details, see article by Heilmann and colleagues on page 4272. - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Cancer Research
Table of Contents
Breaking Advances
Reviews
Priority Report
The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients
Alice Bartolini; Daniela Di Paolo; Alessio Noghero; Daniele Murgia; Angela R. Sementa; Michele Cilli; Renata Pasqualini; Wadih Arap; Federico Bussolino; Mirco Ponzoni; Fabio Pastorino; Serena Marchiò
Integrated Systems and Technologies
Author Choice
A Quantitative System for Studying Metastasis Using Transparent Zebrafish
Silja Heilmann; Kajan Ratnakumar; Erin M. Langdon; Emily R. Kansler; Isabella S. Kim; Nathaniel R. Campbell; Elizabeth B. Perry; Amy J. McMahon; Charles K. Kaufman; Ellen van Rooijen; William Lee; Christine A. Iacobuzio-Donahue; Richard O. Hynes; Leonard I. Zon; Joao B. Xavier; Richard M. White
Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid Tumors
Janean Fidel; Katie C. Kennedy; William S. Dernell; Stacey Hansen; Valorie Wiss; Mark R. Stroud; Joshua I. Molho; Sue E. Knoblaugh; Jeffrey Meganck; James M. Olson; Brad Rice; Julia Parrish-Novak
Microenvironment and Immunology
Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression
Paula J. Hurley; Robert M. Hughes; Brian W. Simons; Jessie Huang; Rebecca M. Miller; Brian Shinder; Michael C. Haffner; David Esopi; Yasunori Kimura; Javaneh Jabbari; Ashley E. Ross; Nicholas Erho; Ismael A. Vergara; Sheila F. Faraj; Elai Davicioni; George J. Netto; Srinivasan Yegnasubramanian; Steven S. An; Edward M. Schaeffer
Molecular and Cellular Pathobiology
TIF1γ Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability
Roxane M. Pommier; Johann Gout; David F. Vincent; Lindsay B. Alcaraz; Nicolas Chuvin; Vanessa Arfi; Sylvie Martel; Bastien Kaniewski; Guillaume Devailly; Geneviève Fourel; Pascal Bernard; Caroline Moyret-Lalle; Stéphane Ansieau; Alain Puisieux; Ulrich Valcourt; Stéphanie Sentis; Laurent Bartholin
The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers
Stéphanie Légaré; Luca Cavallone; Aline Mamo; Catherine Chabot; Isabelle Sirois; Anthony Magliocco; Alexander Klimowicz; Patricia N. Tonin; Marguerite Buchanan; Dana Keilty; Saima Hassan; David Laperrière; Sylvie Mader; Olga Aleynikova; Mark Basik
Therapeutics, Targets, and Chemical Biology
Author Choice
ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated Cancers
Javad Garousi; Sarah Lindbo; Johan Nilvebrant; Mikael Åstrand; Jos Buijs; Mattias Sandström; Hadis Honarvar; Anna Orlova; Vladimir Tolmachev; Sophia Hober
Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition
Margaret Soucheray; Marzia Capelletti; Inés Pulido; Yanan Kuang; Cloud P. Paweletz; Jeffrey H. Becker; Eiki Kikuchi; Chunxiao Xu; Tarun B. Patel; Fatima Al-shahrour; Julián Carretero; Kwok-Kin Wong; Pasi A. Jänne; Geoffrey I. Shapiro; Takeshi Shimamura
Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
Jian-Jun Zhao; Zhang-Bo Chu; Yu Hu; Jianhong Lin; Zhongqiu Wang; Meng Jiang; Ming Chen; Xujun Wang; Yue Kang; Yangsheng Zhou; Triona Ni Chonghaile; Melanie E. Johncilla; Yu-Tzu Tai; Jin Q. Cheng; Antony Letai; Nikhil C. Munshi; Kenneth C. Anderson; Ruben D. Carrasco
Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer
Byunghee Yoo; Amol Kavishwar; Alana Ross; Ping Wang; Doris P. Tabassum; Kornelia Polyak; Natalia Barteneva; Victoria Petkova; Pamela Pantazopoulos; Aseda Tena; Anna Moore; Zdravka Medarova
Tumor and Stem Cell Biology
Correction
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds